Showing results filtered by:
31 Results
Resources for NIAID grantees about the first events that occur after applications go through peer review and are approved for funding.
Last Reviewed: December 18, 2019
Innovative Drug Delivery for Spinal Cord Injury: NurExone's Exosome-Based siRNA Therapy with FDA Endorsement and Expanding Pipeline for Neuronal Regeneration November 14, 2024 Presenter: Dr. Lior Shaltiel, CEO, NurExone Biologic Inc. NurExone is leading the advancement of drug delivery systems for CNS indications and specially in spinal cord injury treatment. Their cutting-edge exosome-based siRNA
Last Reviewed: November 13, 2024
Role of vector saliva in blood feeding by arthropods, in particular determining the structure-function relationships of their components.
Last Reviewed: September 27, 2022
Information for researchers about which changes can be made to grants independently and which require NIAID permission.
Last Reviewed: September 29, 2023
The 202nd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, September 12, 2022. Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:44 a.m. and from 1
Last Reviewed: January 27, 2023
The 206 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Tuesday, January 30, 2024. Dr. Jeanne Marrazzo, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:45 a.m. and from 1
Last Reviewed: May 21, 2024